# Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects

> **NCT01846455** · PHASE4 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 43 (actual)

## Conditions studied

- Hepatic Failure
- Hepatic Impairment
- Chronic Hepatitis C Infection With Hepatic Coma

## Interventions

- **DRUG:** 2.0mg Buprenorphine/0.5mg Naloxone
- **DRUG:** Promethazine

## Key facts

- **NCT ID:** NCT01846455
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01846455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01846455, "Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01846455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*